Relaxin Regulates Myofibroblast Contractility and Protects against Lung Fibrosis
- 31 December 2011
- journal article
- Published by Elsevier BV in The American Journal of Pathology
- Vol. 179 (6), 2751-2765
- https://doi.org/10.1016/j.ajpath.2011.08.018
Abstract
No abstract availableKeywords
Funding Information
- NIH (HL097215)
- American Heart Association Scientist Development (0835432N)
- NIH (HL067967, HL107181)
This publication has 89 references indexed in Scilit:
- miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosisThe Journal of Experimental Medicine, 2010
- Thy-1-Integrin αvβ5 Interactions Inhibit Lung Fibroblast Contraction-induced Latent Transforming Growth Factor-β1 Activation and Myofibroblast DifferentiationPublished by Elsevier BV ,2010
- Regulation of PI3-kinase/Akt signaling by muscle-enriched microRNA-486Proceedings of the National Academy of Sciences of the United States of America, 2010
- Fate-determining mechanisms in epithelial–myofibroblast transition: major inhibitory role for Smad3The Journal of cell biology, 2010
- Relaxin and its role in the development and treatment of fibrosisTranslational Research, 2009
- Mechanotransduction gone awryNature Reviews Molecular Cell Biology, 2009
- Myofibroblast contraction activates latent TGF-β1 from the extracellular matrixThe Journal of cell biology, 2007
- Dual roles of myocardin-related transcription factors in epithelial–mesenchymal transition via slug induction and actin remodelingThe Journal of cell biology, 2007
- Formation and Function of the Myofibroblast during Tissue RepairJournal of Investigative Dermatology, 2007
- Myofibroblasts and mechano-regulation of connective tissue remodellingNature Reviews Molecular Cell Biology, 2002